Report Cover

Global Neurological Biomarkers Market Insights and Forecast to 2027


Neurological Biomarkers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neurological Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
    Proteomics
    Genomics
    Imaging
    Bioinformatics
    Others

Segment by Application
    Diagnostics
    Drug Discovery
    Personalized Medicine
    Others

By Company
    Thermo Fisher Scientific
    Merck
    Quest Diagnostics
    Abbott
    Roche
    Illumina
    Bio-Rad Laboratories
    QIAGEN
    Myriad RBM
    Cisbio Bioassays
    Athena Diagnostics
    BGI
    Wuxi APP
    Aepodia
    Proteome Sciences
    Genewiz

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
1 Study Coverage
    1.1 Neurological Biomarkers Product Introduction
    1.2 Market by Type
        1.2.1 Global Neurological Biomarkers Market Size Growth Rate by Type
        1.4.2 Proteomics
        1.4.3 Genomics
        1.2.4 Imaging
        1.2.5 Bioinformatics
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Neurological Biomarkers Market Size Growth Rate by Application
        1.3.2 Diagnostics
        1.3.3 Drug Discovery
        1.3.4 Personalized Medicine
        1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
    2.1 Global Neurological Biomarkers Sales Estimates and Forecasts 2016-2027
    2.2 Global Neurological Biomarkers Revenue Estimates and Forecasts 2016-2027
    2.3 Global Neurological Biomarkers Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Neurological Biomarkers Regions by Sales
        2.4.1 Global Top Neurological Biomarkers Regions by Sales (2016-2021)
        2.4.2 Global Top Neurological Biomarkers Regions by Sales (2022-2027)
    2.5 Global Top Neurological Biomarkers Regions by Revenue
        2.5.1 Global Top Neurological Biomarkers Regions by Revenue (2016-2021)
        2.5.2 Global Top Neurological Biomarkers Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Neurological Biomarkers Sales by Manufacturers
        3.1.1 Global Top Neurological Biomarkers Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Neurological Biomarkers Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Neurological Biomarkers Sales in 2020
    3.2 Global Neurological Biomarkers Revenue by Manufacturers
        3.2.1 Global Top Neurological Biomarkers Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Neurological Biomarkers Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Neurological Biomarkers Revenue in 2020
    3.3 Global Neurological Biomarkers Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Neurological Biomarkers Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Neurological Biomarkers Sales by Type
        4.1.1 Global Neurological Biomarkers Historical Sales by Type (2016-2021)
        4.1.2 Global Neurological Biomarkers Forecasted Sales by Type (2022-2027)
        4.1.3 Global Neurological Biomarkers Sales Market Share by Type (2016-2027)
    4.2 Global Neurological Biomarkers Revenue by Type
        4.2.1 Global Neurological Biomarkers Historical Revenue by Type (2016-2021)
        4.2.2 Global Neurological Biomarkers Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Neurological Biomarkers Revenue Market Share by Type (2016-2027)
    4.3 Global Neurological Biomarkers Price by Type
        4.3.1 Global Neurological Biomarkers Price by Type (2016-2021)
        4.3.2 Global Neurological Biomarkers Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Neurological Biomarkers Sales by Application
        5.1.1 Global Neurological Biomarkers Historical Sales by Application (2016-2021)
        5.1.2 Global Neurological Biomarkers Forecasted Sales by Application (2022-2027)
        5.1.3 Global Neurological Biomarkers Sales Market Share by Application (2016-2027)
    5.2 Global Neurological Biomarkers Revenue by Application
        5.2.1 Global Neurological Biomarkers Historical Revenue by Application (2016-2021)
        5.2.2 Global Neurological Biomarkers Forecasted Revenue by Application (2022-2027)
        5.2.3 Global Neurological Biomarkers Revenue Market Share by Application (2016-2027)
    5.3 Global Neurological Biomarkers Price by Application
        5.3.1 Global Neurological Biomarkers Price by Application (2016-2021)
        5.3.2 Global Neurological Biomarkers Price Forecast by Application (2022-2027)

6 North America
    6.1 North America Neurological Biomarkers Market Size by Type
        6.1.1 North America Neurological Biomarkers Sales by Type (2016-2027)
        6.1.2 North America Neurological Biomarkers Revenue by Type (2016-2027)
    6.2 North America Neurological Biomarkers Market Size by Application
        6.2.1 North America Neurological Biomarkers Sales by Application (2016-2027)
        6.2.2 North America Neurological Biomarkers Revenue by Application (2016-2027)
    6.3 North America Neurological Biomarkers Market Size by Country
        6.3.1 North America Neurological Biomarkers Sales by Country (2016-2027)
        6.3.2 North America Neurological Biomarkers Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Neurological Biomarkers Market Size by Type
        7.1.1 Europe Neurological Biomarkers Sales by Type (2017-2027)
        7.1.2 Europe Neurological Biomarkers Revenue by Type (2017-2027)
    7.2 Europe Neurological Biomarkers Market Size by Application
        7.2.1 Europe Neurological Biomarkers Sales by Application (2017-2027)
        7.2.2 Europe Neurological Biomarkers Revenue by Application (2017-2027)
    7.3 Europe Neurological Biomarkers Market Size by Country
        7.3.1 Europe Neurological Biomarkers Sales by Country (2017-2027)
        7.3.2 Europe Neurological Biomarkers Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Neurological Biomarkers Market Size by Type
        8.1.1 Asia Pacific Neurological Biomarkers Sales by Type (2018-2027)
        8.1.2 Asia Pacific Neurological Biomarkers Revenue by Type (2018-2027)
    8.2 Asia Pacific Neurological Biomarkers Market Size by Application
        8.2.1 Asia Pacific Neurological Biomarkers Sales by Application (2018-2027)
        8.2.2 Asia Pacific Neurological Biomarkers Revenue by Application (2018-2027)
    8.3 Asia Pacific Neurological Biomarkers Market Size by Region
        8.3.1 Asia Pacific Neurological Biomarkers Sales by Region (2018-2027)
        8.3.2 Asia Pacific Neurological Biomarkers Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Neurological Biomarkers Market Size by Type
        9.1.1 Latin America Neurological Biomarkers Sales by Type (2019-2027)
        9.1.2 Latin America Neurological Biomarkers Revenue by Type (2019-2027)
    9.2 Latin America Neurological Biomarkers Market Size by Application
        9.2.1 Latin America Neurological Biomarkers Sales by Application (2019-2027)
        9.2.2 Latin America Neurological Biomarkers Revenue by Application (2019-2027)
    9.3 Latin America Neurological Biomarkers Market Size by Country
        9.3.1 Latin America Neurological Biomarkers Sales by Country (2019-2027)
        9.3.2 Latin America Neurological Biomarkers Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Neurological Biomarkers Market Size by Type
        6.1.1 Middle East and Africa Neurological Biomarkers Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Neurological Biomarkers Revenue by Type (2016-2027)
    6.2 Middle East and Africa Neurological Biomarkers Market Size by Application
        6.2.1 Middle East and Africa Neurological Biomarkers Sales by Application (2016-2027)
        6.2.2 Middle East and Africa Neurological Biomarkers Revenue by Application (2016-2027)
    6.3 Middle East and Africa Neurological Biomarkers Market Size by Country
        6.3.1 Middle East and Africa Neurological Biomarkers Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Neurological Biomarkers Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 U.A.E

11 Company Profiles
    11.1 Thermo Fisher Scientific
        11.1.1 Thermo Fisher Scientific Corporation Information
        11.1.2 Thermo Fisher Scientific Overview
        11.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Thermo Fisher Scientific Neurological Biomarkers Product Description
        11.1.5 Thermo Fisher Scientific Related Developments
    11.2 Merck
        11.2.1 Merck Corporation Information
        11.2.2 Merck Overview
        11.2.3 Merck Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 Merck Neurological Biomarkers Product Description
        11.2.5 Merck Related Developments
    11.3 Quest Diagnostics
        11.3.1 Quest Diagnostics Corporation Information
        11.3.2 Quest Diagnostics Overview
        11.3.3 Quest Diagnostics Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 Quest Diagnostics Neurological Biomarkers Product Description
        11.3.5 Quest Diagnostics Related Developments
    11.4 Abbott
        11.4.1 Abbott Corporation Information
        11.4.2 Abbott Overview
        11.4.3 Abbott Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 Abbott Neurological Biomarkers Product Description
        11.4.5 Abbott Related Developments
    11.5 Roche
        11.5.1 Roche Corporation Information
        11.5.2 Roche Overview
        11.5.3 Roche Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
        11.5.4 Roche Neurological Biomarkers Product Description
        11.5.5 Roche Related Developments
    11.6 Illumina
        11.6.1 Illumina Corporation Information
        11.6.2 Illumina Overview
        11.6.3 Illumina Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
        11.6.4 Illumina Neurological Biomarkers Product Description
        11.6.5 Illumina Related Developments
    11.7 Bio-Rad Laboratories
        11.7.1 Bio-Rad Laboratories Corporation Information
        11.7.2 Bio-Rad Laboratories Overview
        11.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
        11.7.4 Bio-Rad Laboratories Neurological Biomarkers Product Description
        11.7.5 Bio-Rad Laboratories Related Developments
    11.8 QIAGEN
        11.8.1 QIAGEN Corporation Information
        11.8.2 QIAGEN Overview
        11.8.3 QIAGEN Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
        11.8.4 QIAGEN Neurological Biomarkers Product Description
        11.8.5 QIAGEN Related Developments
    11.9 Myriad RBM
        11.9.1 Myriad RBM Corporation Information
        11.9.2 Myriad RBM Overview
        11.9.3 Myriad RBM Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
        11.9.4 Myriad RBM Neurological Biomarkers Product Description
        11.9.5 Myriad RBM Related Developments
    11.10 Cisbio Bioassays
        11.10.1 Cisbio Bioassays Corporation Information
        11.10.2 Cisbio Bioassays Overview
        11.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
        11.10.4 Cisbio Bioassays Neurological Biomarkers Product Description
        11.10.5 Cisbio Bioassays Related Developments
    11.1 Thermo Fisher Scientific
        11.1.1 Thermo Fisher Scientific Corporation Information
        11.1.2 Thermo Fisher Scientific Overview
        11.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Thermo Fisher Scientific Neurological Biomarkers Product Description
        11.1.5 Thermo Fisher Scientific Related Developments
    11.12 BGI
        11.12.1 BGI Corporation Information
        11.12.2 BGI Overview
        11.12.3 BGI Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
        11.12.4 BGI Product Description
        11.12.5 BGI Related Developments
    11.13 Wuxi APP
        11.13.1 Wuxi APP Corporation Information
        11.13.2 Wuxi APP Overview
        11.13.3 Wuxi APP Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
        11.13.4 Wuxi APP Product Description
        11.13.5 Wuxi APP Related Developments
    11.14 Aepodia
        11.14.1 Aepodia Corporation Information
        11.14.2 Aepodia Overview
        11.14.3 Aepodia Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
        11.14.4 Aepodia Product Description
        11.14.5 Aepodia Related Developments
    11.15 Proteome Sciences
        11.15.1 Proteome Sciences Corporation Information
        11.15.2 Proteome Sciences Overview
        11.15.3 Proteome Sciences Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
        11.15.4 Proteome Sciences Product Description
        11.15.5 Proteome Sciences Related Developments
    11.16 Genewiz
        11.16.1 Genewiz Corporation Information
        11.16.2 Genewiz Overview
        11.16.3 Genewiz Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
        11.16.4 Genewiz Product Description
        11.16.5 Genewiz Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Neurological Biomarkers Value Chain Analysis
    12.2 Neurological Biomarkers Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Neurological Biomarkers Production Mode & Process
    12.4 Neurological Biomarkers Sales and Marketing
        12.4.1 Neurological Biomarkers Sales Channels
        12.4.2 Neurological Biomarkers Distributors
    12.5 Neurological Biomarkers Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Neurological Biomarkers Industry Trends
    13.2 Neurological Biomarkers Market Drivers
    13.3 Neurological Biomarkers Market Challenges
    13.4 Neurological Biomarkers Market Restraints

14 Key Findings in The Global Neurological Biomarkers Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables Table 1. Global Neurological Biomarkers Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Proteomics Table 3. Major Manufacturers of Genomics Table 4. Major Manufacturers of Imaging Table 5. Major Manufacturers of Bioinformatics Table 6. Major Manufacturers of Others Table 7. Global Neurological Biomarkers Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 8. Global Neurological Biomarkers Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 9. Global Neurological Biomarkers Sales by Region (2016-2021) & (K Units) Table 10. Global Neurological Biomarkers Sales Market Share by Region (2016-2021) Table 11. Global Neurological Biomarkers Sales by Region (2016-2021) & (K Units) Table 12. Global Neurological Biomarkers Sales Market Share by Region (2022-2027) Table 13. Global Neurological Biomarkers Revenue by Region (2016-2021) & (US$ Million) Table 14. Global Neurological Biomarkers Revenue Market Share by Region (2016-2021) Table 15. Global Neurological Biomarkers Revenue by Region (2022-2027) & (US$ Million) Table 16. Global Neurological Biomarkers Revenue Market Share by Region (2022-2027) Table 17. Global Neurological Biomarkers Sales by Manufacturers (2016-2021) & (K Units) Table 18. Global Neurological Biomarkers Sales Share by Manufacturers (2016-2021) Table 19. Global Neurological Biomarkers Revenue by Manufacturers (2016-2021) & (US$ Million) Table 20. Global Neurological Biomarkers Revenue Share by Manufacturers (2016-2021) Table 21. Neurological Biomarkers Price by Manufacturers 2016-2021 (USD/Unit) Table 22. Global Neurological Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Global Neurological Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Biomarkers as of 2020) Table 24. Neurological Biomarkers Manufacturing Base Distribution and Headquarters Table 25. Manufacturers Neurological Biomarkers Product Offered Table 26. Date of Manufacturers Enter into Neurological Biomarkers Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Neurological Biomarkers Sales by Type (2016-2021) & (K Units) Table 29. Global Neurological Biomarkers Sales by Type (2022-2027) & (K Units) Table 30. Global Neurological Biomarkers Sales Share by Type (2016-2021) Table 31. Global Neurological Biomarkers Sales Share by Type (2022-2027) Table 32. Global Neurological Biomarkers Revenue by Type (2016-2021) & (US$ Million) Table 33. Global Neurological Biomarkers Revenue by Type (2022-2027) & (US$ Million) Table 34. Global Neurological Biomarkers Revenue Share by Type (2016-2021) Table 35. Global Neurological Biomarkers Revenue Share by Type (2022-2027) Table 36. Neurological Biomarkers Price by Type (2016-2021) & (USD/Unit) Table 37. Global Neurological Biomarkers Price Forecast by Type (2022-2027) & (USD/Unit) Table 38. Global Neurological Biomarkers Sales by Application (2016-2021) & (K Units) Table 39. Global Neurological Biomarkers Sales by Application (2022-2027) & (K Units) Table 40. Global Neurological Biomarkers Sales Share by Application (2016-2021) Table 41. Global Neurological Biomarkers Sales Share by Application (2022-2027) Table 42. Global Neurological Biomarkers Revenue by Application (2016-2021) & (US$ Million) Table 43. Global Neurological Biomarkers Revenue by Application (2022-2027) & (US$ Million) Table 44. Global Neurological Biomarkers Revenue Share by Application (2016-2021) Table 45. Global Neurological Biomarkers Revenue Share by Application (2022-2027) Table 46. Neurological Biomarkers Price by Application (2016-2021) & (USD/Unit) Table 47. Global Neurological Biomarkers Price Forecast by Application (2022-2027) & (USD/Unit) Table 48. North America Neurological Biomarkers Sales by Type (2016-2021) & (K Units) Table 49. North America Neurological Biomarkers Sales by Type (2022-2027) & (K Units) Table 50. North America Neurological Biomarkers Revenue by Type (2016-2021) & (US$ Million) Table 51. North America Neurological Biomarkers Revenue by Type (2022-2027) & (US$ Million) Table 52. North America Neurological Biomarkers Sales by Application (2016-2021) & (K Units) Table 53. North America Neurological Biomarkers Sales by Application (2022-2027) & (K Units) Table 54. North America Neurological Biomarkers Revenue by Application (2016-2021) & (US$ Million) Table 55. North America Neurological Biomarkers Revenue by Application (2022-2027) & (US$ Million) Table 56. North America Neurological Biomarkers Sales by Country (2016-2021) & (K Units) Table 57. North America Neurological Biomarkers Sales by Country (2022-2027) & (K Units) Table 58. North America Neurological Biomarkers Revenue by Country (2016-2021) & (US$ Million) Table 59. North America Neurological Biomarkers Revenue by Country (2022-2027) & (US$ Million) Table 60. Europe Neurological Biomarkers Sales by Type (2016-2021) & (K Units) Table 61. Europe Neurological Biomarkers Sales by Type (2022-2027) & (K Units) Table 62. Europe Neurological Biomarkers Revenue by Type (2016-2021) & (US$ Million) Table 63. Europe Neurological Biomarkers Revenue by Type (2022-2027) & (US$ Million) Table 64. Europe Neurological Biomarkers Sales by Application (2016-2021) & (K Units) Table 65. Europe Neurological Biomarkers Sales by Application (2022-2027) & (K Units) Table 66. Europe Neurological Biomarkers Revenue by Application (2016-2021) & (US$ Million) Table 67. Europe Neurological Biomarkers Revenue by Application (2022-2027) & (US$ Million) Table 68. Europe Neurological Biomarkers Sales by Country (2016-2021) & (K Units) Table 69. Europe Neurological Biomarkers Sales by Country (2022-2027) & (K Units) Table 70. Europe Neurological Biomarkers Revenue by Country (2016-2021) & (US$ Million) Table 71. Europe Neurological Biomarkers Revenue by Country (2022-2027) & (US$ Million) Table 72. Asia Pacific Neurological Biomarkers Sales by Type (2016-2021) & (K Units) Table 73. Asia Pacific Neurological Biomarkers Sales by Type (2022-2027) & (K Units) Table 74. Asia Pacific Neurological Biomarkers Revenue by Type (2016-2021) & (US$ Million) Table 75. Asia Pacific Neurological Biomarkers Revenue by Type (2022-2027) & (US$ Million) Table 76. Asia Pacific Neurological Biomarkers Sales by Application (2016-2021) & (K Units) Table 77. Asia Pacific Neurological Biomarkers Sales by Application (2022-2027) & (K Units) Table 78. Asia Pacific Neurological Biomarkers Revenue by Application (2016-2021) & (US$ Million) Table 79. Asia Pacific Neurological Biomarkers Revenue by Application (2022-2027) & (US$ Million) Table 80. Asia Pacific Neurological Biomarkers Sales by Region (2016-2021) & (K Units) Table 81. Asia Pacific Neurological Biomarkers Sales by Region (2022-2027) & (K Units) Table 82. Asia Pacific Neurological Biomarkers Revenue by Region (2016-2021) & (US$ Million) Table 83. Asia Pacific Neurological Biomarkers Revenue by Region (2022-2027) & (US$ Million) Table 84. Latin America Neurological Biomarkers Sales by Type (2016-2021) & (K Units) Table 85. Latin America Neurological Biomarkers Sales by Type (2022-2027) & (K Units) Table 86. Latin America Neurological Biomarkers Revenue by Type (2016-2021) & (US$ Million) Table 87. Latin America Neurological Biomarkers Revenue by Type (2022-2027) & (US$ Million) Table 88. Latin America Neurological Biomarkers Sales by Application (2016-2021) & (K Units) Table 89. Latin America Neurological Biomarkers Sales by Application (2022-2027) & (K Units) Table 90. Latin America Neurological Biomarkers Revenue by Application (2016-2021) & (US$ Million) Table 91. Latin America Neurological Biomarkers Revenue by Application (2022-2027) & (US$ Million) Table 92. Latin America Neurological Biomarkers Sales by Country (2016-2021) & (K Units) Table 93. Latin America Neurological Biomarkers Sales by Country (2022-2027) & (K Units) Table 94. Latin America Neurological Biomarkers Revenue by Country (2016-2021) & (US$ Million) Table 95. Latin America Neurological Biomarkers Revenue by Country (2022-2027) & (US$ Million) Table 96. Middle East and Africa Neurological Biomarkers Sales by Type (2016-2021) & (K Units) Table 97. Middle East and Africa Neurological Biomarkers Sales by Type (2022-2027) & (K Units) Table 98. Middle East and Africa Neurological Biomarkers Revenue by Type (2016-2021) & (US$ Million) Table 99. Middle East and Africa Neurological Biomarkers Revenue by Type (2022-2027) & (US$ Million) Table 100. Middle East and Africa Neurological Biomarkers Sales by Application (2016-2021) & (K Units) Table 101. Middle East and Africa Neurological Biomarkers Sales by Application (2022-2027) & (K Units) Table 102. Middle East and Africa Neurological Biomarkers Revenue by Application (2016-2021) & (US$ Million) Table 103. Middle East and Africa Neurological Biomarkers Revenue by Application (2022-2027) & (US$ Million) Table 104. Middle East and Africa Neurological Biomarkers Sales by Country (2016-2021) & (K Units) Table 105. Middle East and Africa Neurological Biomarkers Sales by Country (2022-2027) & (K Units) Table 106. Middle East and Africa Neurological Biomarkers Revenue by Country (2016-2021) & (US$ Million) Table 107. Middle East and Africa Neurological Biomarkers Revenue by Country (2022-2027) & (US$ Million) Table 108. Thermo Fisher Scientific Corporation Information Table 109. Thermo Fisher Scientific Description and Major Businesses Table 110. Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 111. Thermo Fisher Scientific Neurological Biomarkers Product Table 112. Thermo Fisher Scientific Recent Developments Table 113. Merck Corporation Information Table 114. Merck Description and Major Businesses Table 115. Merck Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 116. Merck Neurological Biomarkers Product Table 117. Merck Recent Developments Table 118. Quest Diagnostics Corporation Information Table 119. Quest Diagnostics Description and Major Businesses Table 120. Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 121. Quest Diagnostics Neurological Biomarkers Product Table 122. Quest Diagnostics Recent Developments Table 123. Abbott Corporation Information Table 124. Abbott Description and Major Businesses Table 125. Abbott Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 126. Abbott Neurological Biomarkers Product Table 127. Abbott Recent Developments Table 128. Roche Corporation Information Table 129. Roche Description and Major Businesses Table 130. Roche Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 131. Roche Neurological Biomarkers Product Table 132. Roche Recent Developments Table 133. Illumina Corporation Information Table 134. Illumina Description and Major Businesses Table 135. Illumina Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 136. Illumina Neurological Biomarkers Product Table 137. Illumina Recent Developments Table 138. Bio-Rad Laboratories Corporation Information Table 139. Bio-Rad Laboratories Description and Major Businesses Table 140. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 141. Bio-Rad Laboratories Neurological Biomarkers Product Table 142. Bio-Rad Laboratories Recent Developments Table 143. QIAGEN Corporation Information Table 144. QIAGEN Description and Major Businesses Table 145. QIAGEN Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 146. QIAGEN Neurological Biomarkers Product Table 147. QIAGEN Recent Developments Table 148. Myriad RBM Corporation Information Table 149. Myriad RBM Description and Major Businesses Table 150. Myriad RBM Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 151. Myriad RBM Neurological Biomarkers Product Table 152. Myriad RBM Recent Developments Table 153. Cisbio Bioassays Corporation Information Table 154. Cisbio Bioassays Description and Major Businesses Table 155. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 156. Cisbio Bioassays Neurological Biomarkers Product Table 157. Cisbio Bioassays Recent Developments Table 158. Athena Diagnostics Corporation Information Table 159. Athena Diagnostics Description and Major Businesses Table 160. Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 161. Athena Diagnostics Neurological Biomarkers Product Table 162. Athena Diagnostics Recent Developments Table 163. BGI Corporation Information Table 164. BGI Description and Major Businesses Table 165. BGI Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 166. BGI Neurological Biomarkers Product Table 167. BGI Recent Developments Table 168. Wuxi APP Corporation Information Table 169. Wuxi APP Description and Major Businesses Table 170. Wuxi APP Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 171. Wuxi APP Neurological Biomarkers Product Table 172. Wuxi APP Recent Developments Table 173. Aepodia Corporation Information Table 174. Aepodia Description and Major Businesses Table 175. Aepodia Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 176. Aepodia Neurological Biomarkers Product Table 177. Aepodia Recent Developments Table 178. Proteome Sciences Corporation Information Table 179. Proteome Sciences Description and Major Businesses Table 180. Proteome Sciences Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 181. Proteome Sciences Neurological Biomarkers Product Table 182. Proteome Sciences Recent Developments Table 183. Genewiz Corporation Information Table 184. Genewiz Description and Major Businesses Table 185. Genewiz Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 186. Genewiz Neurological Biomarkers Product Table 187. Genewiz Recent Developments Table 188. Key Raw Materials Lists Table 189. Raw Materials Key Suppliers Lists Table 190. Neurological Biomarkers Distributors List Table 191. Neurological Biomarkers Customers List Table 192. Neurological Biomarkers Market Trends Table 193. Neurological Biomarkers Market Drivers Table 194. Neurological Biomarkers Market Challenges Table 195. Neurological Biomarkers Market Restraints Table 196. Research Programs/Design for This Report Table 197. Key Data Information from Secondary Sources Table 198. Key Data Information from Primary Sources List of Figures Figure 1. Neurological Biomarkers Product Picture Figure 2. Global Neurological Biomarkers Market Share by Type in 2020 & 2027 Figure 3. Proteomics Product Picture Figure 4. Genomics Product Picture Figure 5. Imaging Product Picture Figure 6. Bioinformatics Product Picture Figure 7. Others Product Picture Figure 8. Global Neurological Biomarkers Sales Market Share by Application in 2020 & 2027 Figure 9. Diagnostics Figure 10. Drug Discovery Figure 11. Personalized Medicine Figure 12. Others Figure 13. Neurological Biomarkers Report Years Considered Figure 14. Global Neurological Biomarkers Sales 2016-2027 (K Units) Figure 15. Global Neurological Biomarkers Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Neurological Biomarkers Revenue 2016-2027 (US$ Million) Figure 17. Global Neurological Biomarkers Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 18. Global Neurological Biomarkers Sales Market Share by Region (2016-2021) Figure 19. Global Neurological Biomarkers Sales Market Share by Region (2022-2027) Figure 20. North America Neurological Biomarkers Sales YoY (2016-2027) & (K Units) Figure 21. North America Neurological Biomarkers Revenue YoY (2016-2027) & (US$ Million) Figure 22. Europe Neurological Biomarkers Sales YoY (2016-2027) & (K Units) Figure 23. Europe Neurological Biomarkers Revenue YoY (2016-2027) & (US$ Million) Figure 24. Asia-Pacific Neurological Biomarkers Sales YoY (2016-2027) & (K Units) Figure 25. Asia-Pacific Neurological Biomarkers Revenue YoY (2016-2027) & (US$ Million) Figure 26. Latin America Neurological Biomarkers Sales YoY (2016-2027) & (K Units) Figure 27. Latin America Neurological Biomarkers Revenue YoY (2016-2027) & (US$ Million) Figure 28. Middle East & Africa Neurological Biomarkers Sales YoY (2016-2027) & (K Units) Figure 29. Middle East & Africa Neurological Biomarkers Revenue YoY (2016-2027) & (US$ Million) Figure 30. The Top 10 and Top 5 Players Market Share by Neurological Biomarkers Sales in 2020 Figure 31. The Top 10 and Top 5 Players Market Share by Neurological Biomarkers Revenue in 2020 Figure 32. Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 33. Global Neurological Biomarkers Sales Market Share by Type (2016-2027) Figure 34. Global Neurological Biomarkers Revenue Market Share by Type (2016-2027) Figure 35. Global Neurological Biomarkers Sales Market Share by Application (2016-2027) Figure 36. Global Neurological Biomarkers Revenue Market Share by Application (2016-2027) Figure 37. North America Neurological Biomarkers Sales Market Share by Type (2016-2027) Figure 38. North America Neurological Biomarkers Revenue Market Share by Type (2016-2027) Figure 39. North America Neurological Biomarkers Sales Market Share by Application (2016-2027) Figure 40. North America Neurological Biomarkers Revenue Market Share by Application (2016-2027) Figure 41. North America Neurological Biomarkers Sales Share by Country (2016-2027) Figure 42. North America Neurological Biomarkers Revenue Share by Country (2016-2027) Figure 43. U.S. Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 44. Canada Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 45. Europe Neurological Biomarkers Sales Market Share by Type (2016-2027) Figure 46. Europe Neurological Biomarkers Revenue Market Share by Type (2016-2027) Figure 47. Europe Neurological Biomarkers Sales Market Share by Application (2016-2027) Figure 48. Europe Neurological Biomarkers Revenue Market Share by Application (2016-2027) Figure 49. Europe Neurological Biomarkers Sales Share by Country (2016-2027) Figure 50. Europe Neurological Biomarkers Revenue Share by Country (2016-2027) Figure 51. Germany Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 52. France Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 53. U.K. Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 54. Italy Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 55. Russia Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 56. Asia Pacific Neurological Biomarkers Sales Market Share by Type (2016-2027) Figure 57. Asia Pacific Neurological Biomarkers Revenue Market Share by Type (2016-2027) Figure 58. Asia Pacific Neurological Biomarkers Sales Market Share by Application (2016-2027) Figure 59. Asia Pacific Neurological Biomarkers Revenue Market Share by Application (2016-2027) Figure 60. Asia Pacific Neurological Biomarkers Sales Share by Region (2016-2027) Figure 61. Asia Pacific Neurological Biomarkers Revenue Share by Region (2016-2027) Figure 62. China Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 63. Japan Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 64. South Korea Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 65. India Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 66. Australia Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 67. Taiwan Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 68. Indonesia Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 69. Thailand Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 70. Malaysia Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 71. Philippines Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 72. Latin America Neurological Biomarkers Sales Market Share by Type (2016-2027) Figure 73. Latin America Neurological Biomarkers Revenue Market Share by Type (2016-2027) Figure 74. Latin America Neurological Biomarkers Sales Market Share by Application (2016-2027) Figure 75. Latin America Neurological Biomarkers Revenue Market Share by Application (2016-2027) Figure 76. Latin America Neurological Biomarkers Sales Share by Country (2016-2027) Figure 77. Latin America Neurological Biomarkers Revenue Share by Country (2016-2027) Figure 78. Mexico Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 79. Brazil Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 80. Argentina Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 81. Middle East and Africa Neurological Biomarkers Sales Market Share by Type (2016-2027) Figure 82. Middle East and Africa Neurological Biomarkers Revenue Market Share by Type (2016-2027) Figure 83. Middle East and Africa Neurological Biomarkers Sales Market Share by Application (2016-2027) Figure 84. Middle East and Africa Neurological Biomarkers Revenue Market Share by Application (2016-2027) Figure 85. Middle East and Africa Neurological Biomarkers Sales Share by Country (2016-2027) Figure 86. Middle East and Africa Neurological Biomarkers Revenue Share by Country (2016-2027) Figure 87. Turkey Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 88. Saudi Arabia Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 89. U.A.E Neurological Biomarkers Revenue (2016-2027) & (US$ Million) Figure 90. Neurological Biomarkers Value Chain Figure 91. Neurological Biomarkers Production Process Figure 92. Channels of Distribution Figure 93. Distributors Profiles Figure 94. Bottom-up and Top-down Approaches for This Report Figure 95. Data Triangulation Figure 96. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us